The country’s regulator on food, drugs and cosmetics is looking to speed up its approval process, targeting to cut by half ...

Global and US biotech shares have recovered from their lows on signs that the chaos created by the Trump administration is subsiding.

As artificial food dyes are becoming increasingly restricted at state and federal levels, some manufacturers are looking to ...

US FDA grants fast track designation to OKYO Pharma’s urcosimod to treat neuropathic corneal pain: London Saturday, May 3, 2025, 17:00 Hrs [IST] OKYO Pharma Limited, an ophthalm ...

The Trump administration is working to speed up the approval process for oil and gas projects. Interior Secretary Doug Burgum ...

The therapy leverages the company’s intravitreal vector, R100, invented using the Therapeutic Vector Evolution platform.

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...

The FDA granted fast track designation to urcosimod to treat neuropathic corneal pain, according to a press release from Okyo Pharma. Urcosimod, formerly called OK-101, is a “lipid conjugated chemerin ...

No, red dye 3 and red dye 40 are not the same. Red dye 40, made of a chemical compound called Allura red AC, is already ...

INX-315, a CDK2 inhibitor, gained FDA fast track status in CCNE1-positive platinum-resistant/refractory ovarian cancer.

Urcosimod is a lipid conjugated ChemR23 chemerin peptide agonist that is designed to reduce inflammation and pain in the eye.

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...